Antibodies of SLTM


1 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
SLTMProduct_ID: A302-834A
Lot_ID: 1
Source: Bethyl Labs
Target Name: SLTM-human		 HepG2_Bethyl_A302-834A_1_SLTM.png<br>Caption: IP-Western Blot analysis of HepG2 whole cell lysate using SLTM specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-SLTM antibody (lanes under 'SLTM').
 SLTM_Secondary_Western.png<br>Caption: Western blot following shRNA against SLTM in K562 and HepG2 whole cell lysate using SLTM specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against SLTM. Lanes 5-8 follow the same pattern, but in HepG2. SLTM protein appears as the green band, Tubulin serves as a control and appears in red.
 K562_Bethyl_A302-834A_1_SLTM.png<br>Caption: IP-Western Blot analysis of K562 whole cell lysate using SLTM specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-SLTM antibody (lanes under 'SLTM').
 SLTM_Secondary_Western.png<br>Caption: Western blot following shRNA against SLTM in K562 and HepG2 whole cell lysate using SLTM specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against SLTM. Lanes 5-8 follow the same pattern, but in HepG2. SLTM protein appears as the green band, Tubulin serves as a control and appears in red.